Clinical Trial 51494

Dallas, TX 75224



Wake Research is enrolling individuals in a clinical research study for a cytomegalovirus (CMV) vaccine. Compensation is available for participation. Insurance is not needed to participate in this study.

What is CMV?
CMV is a common virus that is often overlooked because healthy people who get it rarely show symptoms.
But if a woman becomes infected with CMV while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects, including hearing loss, or even death in very severe cases.

What is the CMVictory Trial?
The goal of this clinical trial is to evaluate the efficacy and safety of an investigational vaccine called mRNA-1647 against CMV infection.

CMV is the number one infection that causes birth defects in the U.S. and one of the most common infectious causes of birth defects globally.

To qualify, you must be:

  • A female between the ages of 16-40
  • In generally good health
  • In close contact with at least one child 5 years of age or younger for at least 8 hours a week, if age 20 or older
  • Not pregnant or planning on becoming pregnant within the next 9 months

Qualified Participants May Receive:

Qualified participants will receive:

  • Compensation for time and travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.